C0332326||Gleason grade grouping
C0600139||prostate cancer
C1514474||prognostic value
C0078988||Asian
C0025266||men
C1708333||International Society of Urological Pathology
C0332326||Grade Groups
C0332326||Grade Groups
C1547383||Epstein
C3203027||Gleason score
C3203027||Gleason score
C0425382||adopted
C2603343||studies
C0043157||Caucasian populations
C0332326||GG system
C0015031||mixed-ethnicity
C0599755||cohort
C0078988||Asian
C0025266||men
C0194810||radical prostatectomies
C0194810||radical prostatectomies
C3203027||Gleason score
C0005558||biopsy
C0194810||RP
C0332326||Grade Groups
C3203027||Gleason score
C3203027||Gleason score
C3203027||Gleason score
C3203027||Gleason score
C3203027||Gleason score
C2985506||Biochemical recurrence
C0194810||RP
C0138741||prostate-specific antigen
C0138741||prostate-specific antigen
C0194810||RP
C0138741||prostate-specific antigen
C2985506||biochemical recurrence
C0332326||Gleason GG
C0005558||biopsy
C0033573||prostatectomy
C0332326||Grade Groups
C2985506||biochemical recurrence
C0332326||GG system
C0005558||biopsy
C0194810||RP
C3203027||Gleason score
C2603343||study
C1519941||validates
C0332326||GG system
C0015031||mixed-ethnicity population
C0078988||Asian
C0025266||men
C0332326||Grade Groups
C2985506||biochemical recurrence
C1516615||clinical management
C0600139||prostate cancer